BRO vs. PVLA

Last updated Jun 24, 2026

BRO (Brown & Brown, Inc.) and PVLA (Palvella Therapeutics, Inc) are both stocks. BRO operates in Insurance Brokers (Financial Services), while PVLA operates in Biotechnology (Healthcare). Over the past year, BRO returned -45.06% vs 426.53% for PVLA. At a correlation of -0.00, they often move in opposite directions.

Performance

BRO vs. PVLA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Brown & Brown, Inc. (BRO) and Palvella Therapeutics, Inc (PVLA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BRO achieves a -23.82% return, which is significantly lower than PVLA's 13.38% return.

BRO

• 1D: 3.71%
• 1M: 4.46%
• YTD: -23.82%
• 6M: -24.07%
• 1Y: -45.06%
• 3Y*: -2.44%
• 5Y*: 3.28%
• 10Y*: 13.98%

PVLA

• 1D: -0.13%
• 1M: 4.11%
• YTD: 13.38%
• 6M: 18.36%
• 1Y: 426.53%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BRO vs. PVLA - Yearly Performance Comparison

	2026 (YTD)	2025	2024
BRO Brown & Brown, Inc.	-23.82%	-21.37%	-2.08%
PVLA Palvella Therapeutics, Inc	13.38%	772.25%	-8.27%

Correlation

The correlation between BRO and PVLA is -0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.08
Correlation (All Time) Calculated using the full available price history since Dec 16, 2024	-0.00

Fundamentals

EPS BRO : $4.76 PVLA : -$3.75
Total Revenue (TTM) BRO : $6.43B PVLA : $0.00
Gross Profit (TTM) BRO : $3.82B PVLA : $0.00
EBITDA (TTM) BRO : $1.51B PVLA : -$14.75M

Return for Risk

BRO vs. PVLA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BRO

BRO Risk / Return Rank: 4
BRO Sharpe Ratio Rank: 0
BRO Sortino Ratio Rank: 1
BRO Omega Ratio Rank: 2
BRO Calmar Ratio Rank: 7
BRO Martin Ratio Rank: 7

PVLA

PVLA Risk / Return Rank: 97
PVLA Sharpe Ratio Rank: 99
PVLA Sortino Ratio Rank: 97
PVLA Omega Ratio Rank: 95
PVLA Calmar Ratio Rank: 99
PVLA Martin Ratio Rank: 98

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BRO vs. PVLA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Brown & Brown, Inc. (BRO) and Palvella Therapeutics, Inc (PVLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BRO	PVLA	Difference
Sharpe ratio: Return per unit of total volatility	-1.58	5.32	-6.90
Sortino ratio: Return per unit of downside risk	-2.34	4.47	-6.81
Omega ratio: Gain probability vs. loss probability	0.70	1.54	-0.83
Calmar ratio: Return relative to maximum drawdown	-0.89	13.82	-14.72
Martin ratio: Return relative to average drawdown	-1.46	31.14	-32.60

BRO vs. PVLA - Sharpe Ratio Comparison

The current BRO Sharpe Ratio is -1.58, which is lower than the PVLA Sharpe Ratio of 5.32. The chart below compares the historical Sharpe Ratios of BRO and PVLA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BRO vs. PVLA - Drawdown Comparison

The maximum BRO drawdown since its inception was -55.85%, which is greater than PVLA's maximum drawdown of -31.48%. Use the drawdown chart below to compare losses from any high point for BRO and PVLA.

Drawdown Indicators

	BRO	PVLA	Difference
Max Drawdown Largest peak-to-trough decline	-55.85%	-31.48%	-24.37%
Max Drawdown (1Y) Largest decline over 1 year	-50.55%	-31.11%	-19.44%
Max Drawdown (3Y) Largest decline over 3 years	-55.85%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-55.85%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-55.85%	—	—
Current Drawdown Current decline from peak	-50.96%	-19.99%	-30.97%
Average Drawdown Average peak-to-trough decline	-13.57%	-11.16%	-2.41%
Ulcer Index Depth and duration of drawdowns from previous peaks	30.94%	13.79%	+17.15%

Volatility

BRO vs. PVLA - Volatility Comparison

The current volatility for Brown & Brown, Inc. (BRO) is 8.14%, while Palvella Therapeutics, Inc (PVLA) has a volatility of 19.68%. This indicates that BRO experiences smaller price fluctuations and is considered to be less risky than PVLA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BRO	PVLA	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.14%	19.68%	-11.54%
Volatility (6M) Calculated over the trailing 6-month period	21.98%	61.91%	-39.93%
Volatility (1Y) Calculated over the trailing 1-year period	28.66%	80.85%	-52.19%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	24.89%	82.11%	-57.22%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	23.71%	82.11%	-58.40%

Dividends

BRO vs. PVLA - Dividend Comparison

BRO's dividend yield for the trailing twelve months is around 1.07%, while PVLA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BRO Brown & Brown, Inc.	1.07%	0.77%	0.53%	0.67%	0.74%	0.54%	0.73%	0.82%	1.11%	1.08%	1.12%	1.41%
PVLA Palvella Therapeutics, Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both BRO and PVLA in my portfolio?

BRO and PVLA have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BRO or PVLA?

PVLA has higher volatility (19.68%) compared to BRO (8.14%). In terms of maximum drawdown, BRO dropped -55.85% vs PVLA's -31.48%.

Which has better risk-adjusted returns?

PVLA currently has the higher Sharpe Ratio (5.32 vs -1.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.